Meanwhile, multiple studies have reported that microbiome or their metabolites can enhance the anti-tumor effect of PD1 to a certain extent (13, 14), and tumor growth can be inhibited by injecting modified bacteria that continuously express arginine into the tumor microenvironment (15). The gene discussed is PDCD1; the disease is neoplasm.